[68Ga]Ga-3BP-DLL3

N/A

Report date: 2025/11/20 16:04:11

NME

Base Information

Drug Name[68Ga]Ga-3BP-DLL3

Drug Alias Name[68Ga]Ga-3BP-DLL368Ga-3BP-DLL3

ClassificationRadiation-emitting products > Radionuclide Drug ConjugatesRadiation-emitting products > Nuclides > Gallium > 68GaRadiation-emitting products > Radioactive diagnostic agent +[4]

Mechanisms of ActionDelta-like protein 3 binders

TargetsDelta-like protein 3

Therapy Area/IndicationsSmall Cell Lung Carcinoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermany

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator Companies3B Pharmaceuticals GmbH

China Registration ClassN/A

Develop Information

Active Companies3B Pharmaceuticals GmbH

Inactive CompaniesN/A

Active IndicationsSmall Cell Lung Carcinoma

Inactive IndicationsN/A

Other Information

ATC CodeN/A